Cost-Benefit of Stockpiling Drugs for Influenza Pandemic

We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Balicer, Ran D., Huerta, Michael, Davidovitch, Nadav, Grotto, Itamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2005
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320484/
https://www.ncbi.nlm.nih.gov/pubmed/16102319
http://dx.doi.org/10.3201/eid1108.041156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3320484/
https://www.ncbi.nlm.nih.gov/pubmed/16102319
http://dx.doi.org/10.3201/eid1108.041156

Ejemplares similares